Translarna

PTC deepens layoffs as DMD drug faces loss of authorization across Europe
PTC deepens layoffs as DMD drug faces loss of authorization across Europe
Fierce Biotech
PTC Therapeutics
DMD
layoffs
Europe
Translarna
Flag link:
After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe
After FDA setback, PTC Therapeutics' DMD drug Translarna faces possible market withdrawal in Europe
Fierce Pharma
PTC Therapeutics
DMD
Translarna
Europe
Flag link:
PTC Ready to Take Another Shot at FDA Approval of DMD Drug
PTC Ready to Take Another Shot at FDA Approval of DMD Drug
BioSpace
PTC Therapeutics
Translarna
FDA
Duchenne Muscular Dystrophy
Flag link:
PTC aims again for FDA review of Duchenne drug despite latest miss
PTC aims again for FDA review of Duchenne drug despite latest miss
BioPharma Dive
PTC Therapeutics
Translarna
Duchenne Muscular Dystrophy
FDA
Flag link:
Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday
Why PTC Therapeutics Dropped 30.6% Today After Jumping 27.5% Yesterday
Motley Fool
PTC Therapeutics
risdiplam
Biogen
Ionis Pharmaceuticals
spinal muscular atrophy
Sarepta Therapeutics
Translarna
Emflaza
Flag link:
No Charm: PTC’s Duchenne Drug Rejected by FDA for Third Time
No Charm: PTC’s Duchenne Drug Rejected by FDA for Third Time
Xconomy
PTC Therapeutics
Duchenne Muscular Dystrophy
FDA
Translarna
Flag link:
Duchenne muscular dystrophy
Duchenne muscular dystrophy
Motley Fool
Duchenne Muscular Dystrophy
PTC Therapeutics
Translarna
Axovant Sciences
Alzheimer's disease
NASH
Gilead Sciences
Flag link:
Key FDA Regulatory Events to Watch Out for in Sep 2017
Key FDA Regulatory Events to Watch Out for in Sep 2017
Yahoo/Zacks.com
FDA
Mylan Labs
Herceptin
biosimilars
trastuzumab
Shingrix
GSK
Pfizer
Sutent
PTC Therapeutics
Translarna
Amgen
Allergan
Avastin
Flag link:
3 Biotech Stocks That Could Soar in September
3 Biotech Stocks That Could Soar in September
Motley Fool
biotech
fitusiran
Alnylam
PTC Therapeutics
Translarna
Sarepta
Exondys 51
Flag link:
Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
Bad News Biotechs: What's Next for Juno and PTC Therapeutics?
Motley Fool
Juno Therapeutics
PTC Therapeutics
CAR-T
Celgene
cystic fibrosis
Translarna
Flag link:
PTC shares plunge anew after FDA slaps down Duchenne drug for a second time
PTC shares plunge anew after FDA slaps down Duchenne drug for a second time
Endpoints
PTC Therapeutics
FDA
Duchenne Muscular Dystrophy
Translarna
Flag link:
Duchenne drug rejected in US is available in England
Duchenne drug rejected in US is available in England
Pharma Times
Duchenne Muscular Dystrophy
England
PTC Therapeutics
Translarna
Flag link:
PTC Therapeutics Drug Doesn't Meet Goal in Duchenne Trial
PTC Therapeutics Drug Doesn't Meet Goal in Duchenne Trial
Bloomberg
PTC Therapeutics
Duchenne Muscular Dystrophy
clinical trials
Translarna
Flag link:
3 Drugmakers Facing a Pivotal 2015
3 Drugmakers Facing a Pivotal 2015
Motley Fool
PTC Therapeutics
Translarna
GW Pharma
Isis Pharmaceuticals
Flag link:
Pfizer bets on Duchenne MD treatment
Pfizer bets on Duchenne MD treatment
Medical Marketing and Media
Pfizer
Duchenne Muscular Dystrophy
Translarna
Flag link:
Why a bigger deal hasn't been made of the world's first approval of a Duchenne drug
Why a bigger deal hasn't been made of the world's first approval of a Duchenne drug
Bizjournals.com
Duchenne Muscular Dystrophy
drug approvals
PTC Therapeutics
Translarna
Flag link:
Surprising Drug Approval: Time to Buy? (video)
Surprising Drug Approval: Time to Buy? (video)
Motley Fool
multiple sclerosis
MS
PTC Therapeutics
Translarna
Flag link: